✦ LIBER ✦

P-796 A randomized phase II trial of pemetrexed (P) plus cisplatin (cis) or carboplatin (carbo) in extensive stage small cell lung cancer (ES-SCLC)

✍ Scribed by Socinski, M.; Weissman, C.; Hart, L.; Beck, J.; Choksi, J.; Hanson, J.; Prager, D.; Bloss, L.; Ye, Z.; Obasaju, C.

Book ID: 122752607
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 268 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(05)81289-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-778 A phase II trial of carboplatin an

P-778 A phase II trial of carboplatin and irinotecan as first-line therapy for extensive stage small cell lung cancer (ES-SCLC): Preliminary results

✍ Laskin, J.; Shirley, B.; Dobbs, T.; Bi, J.; Carbone, D.; Johnson, D.; Sandler, A 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Phase III randomized double blind placeb

Phase III randomized double blind placebo controlled trial of cisplatin(P) and etoposide (E) plus megestrol acetate (M)/placebo in extensive stage small cell lung cancer (SCLC)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Novel Doublets in Extensive-Stage Small-

Novel Doublets in Extensive-Stage Small-Cell Lung Cancer: A Randomized Phase II Study of Topotecan Plus Cisplatin or Paclitaxel (CALGB 9430)

✍ Alan P. Lyss; James E. Herndon II; Thomas J. Lynch Jr; Andrew T. Turrisi; Doroth 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 141 KB

Commentary on “Novel Doublets in Extensi

Commentary on “Novel Doublets in Extensive-Stage Small-Cell Lung Cancer: A Randomized Phase II Study of Topotecan Plus Cisplatin or Paclitaxel (CALGB 9430)”

✍ Raymond P. Abratt 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 61 KB

O-156 Randomized, phase III trial compar

O-156 Randomized, phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated, extensive-stage, small-cell lung cancer (SCLC)

✍ Langer, C.; Hanna, N.; Einhorn, L.; Sandler, A.; Ansari, R.; Ellis, P.; Byrne, M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 278 KB

Randomized Phase II and Pharmacogenetic

Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non-Small-Cell Lung Cancer

✍ Smit, E. F.; Burgers, S. A.; Biesma, B.; Smit, H. J.M.; Eppinga, P.; Dingemans, 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 181 KB